Arecor Therapeutics plc (AREC) ORD GBP0.01
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
63.50p
63.14p
82.50p
£23.98 million
63.50p
62.00p
35.40p
n/a
0.00p (0.00%) Previous:
0.00p
32,920
n/a
1,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 5.05 | 4.57 |
| Profit before tax (£m) | (10.62) | (8.90) |
| Adjusted EPS (p): | (0.31) | (0.28) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Arecor enters formulation partnership with Skye Bioscience
19 May 2025 11:59
-
Arecor enters collaboration with unnamed global pharma major
26 March 2025 14:51
-
Revenue higher, cash reserves fall at Arecor
3 February 2025 14:40
-
Holding(s) in Company
28 August 2025 12:00
-
Change of Auditor
8 August 2025 07:00
-
Arecor Establishes New Scientific Advisory Board
14 July 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.